- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
CSL Ltd (CSL)
CSL Ltd stock price live, this page displays ASX CSL stock exchange data. View the CSL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the CSL Ltd real time stock price chart below.
What Is the CSL Ltd Stock Price Today?
The CSL Ltd stock price today is 142.22.
What Is the Stock Symbol for CSL Ltd?
The stock symbol for CSL Ltd is ""CSL.""
What Stock Exchange Does CSL Ltd Trade On?
CSL Ltd is listed and trades on the Sydney stock exchange.
Is CSL Ltd a Good Stock to Buy?
Determining whether CSL Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CSL quote. (ISIN: AU000000CSL8) - Test -{{UPSIDE_OR_DOWNSIDE}} - {{DIVIDEND_YIELD}} - {{CURRENT_YEAR}}
What Is the CSL Ltd Stock Price Today?
The CSL Ltd stock price today is 142.22.
What Is the Stock Symbol for CSL Ltd?
The stock symbol for CSL Ltd is ""CSL.""
What Stock Exchange Does CSL Ltd Trade On?
CSL Ltd is listed and trades on the Sydney stock exchange.
Is CSL Ltd a Good Stock to Buy?
Determining whether CSL Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CSL quote. (ISIN: AU000000CSL8) - Test -{{UPSIDE_OR_DOWNSIDE}} - {{DIVIDEND_YIELD}} - {{CURRENT_YEAR}}
142.22
-4.05(-2.77%)
Closed·
Fair Value
An estimate of a CSL's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
140.93
145.00
52 wk Range
140.93
275.79
Trading near 52-week Low
1/2
Fair Value
An estimate of a CSL's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
140.93145.00
52 wk Range
140.93275.79
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
CSL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a CSL's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
212.37
Upside
+49.32%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
- Csl Limited receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Csl Limited receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. This segment also offers therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. It also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.
CSL Ltd Earnings Call Summary for H1/2026
- CSL Limited reported an 81% drop in net profit after tax for H1 2026 due to one-off costs, with revenue falling 4% to $8.3 billion and stock price declining 11.77% to $162.03.
- Despite financial challenges, the company maintained its interim dividend at $1.30 per share and reaffirmed its full-year guidance, expecting double-digit IG growth in H2.
- Interim CEO Gordon Naylor announced a transformation program targeting $550 million in annual cost savings by FY2028, while projecting high single-digit NPAT growth for FY2027-FY2028.
- Management anticipates recovery in albumin sales in China and continues to focus on margin expansion, while acknowledging challenges in KCENTRA, perioperative bleeding segments, and Medicare Part D impacts.
Last Updated: 11/02/2026, 01:38
Read Full TranscriptCompare CSL to Peers and Sector
Metrics to compare | CSL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCSLPeersSector | |
|---|---|---|---|---|
P/E Ratio | 35.4x | 23.4x | −0.5x | |
PEG Ratio | −0.72 | 0.12 | 0.00 | |
Price/Book | 2.6x | 2.7x | 2.6x | |
Price / LTM Sales | 3.2x | 2.7x | 3.2x | |
Upside (Analyst Target) | 38.9% | 39.5% | 51.2% | |
Fair Value Upside | Unlock | 14.2% | 7.3% | Unlock |
Analyst Ratings
11 Buy
5 Hold
0 Sell
Ratings:
16 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 212.37
(+49.32% Upside)
Earnings
Latest Release
Aug 18, 2025
EPS / Forecast
2.04 / 2.70
Revenue / Forecast
7.08B / 10.203B
People Also Watch
FAQ
What Is the CSL (CSL) Stock Price Today?
The CSL stock price today is 142.22 AUD.
What Stock Exchange Does CSL Trade On?
CSL is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for CSL?
The stock symbol for CSL is "CSL."
What Is the CSL Market Cap?
As of today, CSL market cap is 68.42B AUD.
What Is CSL's Earnings Per Share (TTM)?
The CSL EPS (TTM) is 2.86.
From a Technical Analysis Perspective, Is CSL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has CSL Stock Split?
CSL has split 1 times.
How Many Employees Does CSL Have?
CSL has 29904 employees.
What is the current trading status of CSL (CSL)?
As of Mar 09, 2026, CSL (CSL) is trading at a price of 142.22 AUD, with a previous close of 146.27 AUD. The stock has fluctuated within a day range of 140.93 AUD to 145.00 AUD, while its 52-week range spans from 140.93 AUD to 275.79 AUD.
What Is CSL (CSL) Price Target According to Analysts?
The average 12-month price target for CSL is 212.37 AUD, with a high estimate of 272.27752424 AUD and a low estimate of 176.47604107 AUD. 11 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +49.32% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.